JANUS CAPITAL GROUP
Janus Capital Group is a global investment management firm managing $160 billion in global assets through product offerings across growth, mathematical, value and fixed-income. They work hard, think smart, and exist to create success for their clients.
JANUS CAPITAL GROUP
Industry:
Asset Management Professional Services Risk Management
Founded:
1969-01-01
Status:
Active
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail Pound Sterling Google Adsense Mimecast Atlassian Cloud Zoom Video Conferencing Zoom
Similar Organizations
Two Rivers Capital Consulting
Two Rivers Capital Consulting provides tailored investment strategies, ETF, asset, money, risk, and wealth management advisory services.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Company's stock symbol is NYSE:JNS
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-10-03 | Henderson Global Investors | Henderson Global Investors acquired by Janus Capital Group | N/A |
| 2014-12-01 | Velocity Shares | Velocity Shares acquired by Janus Capital Group | 30 M USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-02-08 | Highview Power | Janus Capital Group investment in Corporate Round - Highview Power | N/A |
| 2018-03-21 | Bigfoot Biomedical | Janus Capital Group investment in Series B - Bigfoot Biomedical | 18 M USD |
| 2017-07-18 | Silk Road Medical | Janus Capital Group investment in Series C - Silk Road Medical | 47 M USD |
| 2017-03-30 | Solid Biosciences | Janus Capital Group investment in Series C - Solid Biosciences | 50 M USD |
| 2015-12-28 | Lyft | Janus Capital Group investment in Series F - Lyft | 1000 M USD |
| 2015-09-08 | AveXis | Janus Capital Group investment in Series D - AveXis | 65 M USD |
| 2015-09-01 | Intellia Therapeutics | Janus Capital Group investment in Series B - Intellia Therapeutics | 70 M USD |
| 2015-06-23 | Clementia Pharmaceuticals | Janus Capital Group investment in Venture Round - Clementia Pharmaceuticals | 60 M USD |
| 2015-05-20 | REGENXBIO | Janus Capital Group investment in Series D - REGENXBIO | 70.5 M USD |
| 2015-04-09 | Edge Therapeutics | Janus Capital Group investment in Series C - Edge Therapeutics | 56 M USD |